Jilin Aodong Pharmaceutical Group (000623.SZ) Earnings Analysis
Jilin Aodong Pharmaceutical Group (000623.SZ) has no confirmed upcoming earnings date. Trailing P/E 7.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000623.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 000623.SZ. This page updates as the calendar is published.
000623.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.868 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.678 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.267 CNY | n/a | n/a | n/a |
000623.SZ valuation and analyst view
| Trailing P/E | 7.50 |
|---|---|
| Trailing EPS | 2.435 CNY |
| Price / book | 0.66 |
| Dividend yield | 2.73% |
| Market cap | 21.90B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jilin Aodong Pharmaceutical Group (000623.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 000623.SZ. This page updates as the calendar is published.
Did 000623.SZ beat earnings last quarter?
Consensus estimate data was not available for 000623.SZ's 2025-09-29 report.
What is 000623.SZ's current P/E ratio and EPS?
000623.SZ trades at a trailing P/E of 7.50 on trailing EPS of 2.4346890769067913 CNY.
What do analysts rate 000623.SZ?
000623.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.